Chairman, President and CEO of Allergan Inc. David E Pyott I
sold 616,300 shares on 10/05/2012 at an normal price of $93.73. Allergan Inc.
is a giver of eye care & specialty pharmaceutical products throughout the
globe with products in the eye care pharmaceutical, ophthalmic surgical device,
over-the-counter contact lens care, movement disorder & dermatological
markets.
CEO of Tibco Software Inc. ( TIBX ) Vivek Ranadive sold 542,000 shares on 10/05/2012 at
an average price of $29.01. Tibco Software Inc. is a giver of software
solutions that enable businesses to put together interior operations, industry
partners & client channels in real-time. Tibco Software Inc. has a market
cap of $4.65 billion; its shares were deal at around $29.1 with a P/E ratio of
31.2 &P/S ratio of 5.1. Tibco Software Inc. had a yearly normal earnings
increase of 23.6% over the past five years.
Total incomes were $255.0 million & net income of $26.1 million for Tibco
Software Inc.'s third quarter results.
CEO Vivek Ranadive sold 542,000 shares of TIBX stock on 10/05/2012 at the normal price of $29.01. Executive Vice leader & CFO Sydney Carey sold 42,000 shares of TIBX stock in July & October. Managerial Vice President & COO Murray D. Rode, Director Narendra Gupta & Executive Vice President Products & Engineering Thomas J. Laffey sold 164,053 shares of TIBX stock in July, August & October.
CEO Vivek Ranadive sold 542,000 shares of TIBX stock on 10/05/2012 at the normal price of $29.01. Executive Vice leader & CFO Sydney Carey sold 42,000 shares of TIBX stock in July & October. Managerial Vice President & COO Murray D. Rode, Director Narendra Gupta & Executive Vice President Products & Engineering Thomas J. Laffey sold 164,053 shares of TIBX stock in July, August & October.
No comments:
Post a Comment